相关实验视频
Updated: Jul 15, 2025
08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
1.7K
血液透析患者对BNT-162b2的低幽默反应的危险因素
Clinical nephrology
|October 2, 2023
概括
接受Pfizer-BioNTech COVID-19疫苗的血液透析患者表现出较低的免疫反应,与较高的并发症负担,年龄较大和特定生物标志物相关. 中心静脉导管也与这种脆弱人群中较弱的疫苗反应有关.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 维持血液透析 (HD) 患者面临SARS-CoV-2感染和死亡的风险增加.
- 大规模接种疫苗对于预防HD患者感染至关重要.
- 这项研究调查了影响BNT-162b2疫苗响应的因素.
研究的目的:
- 在血液透析患者中识别与对BNT-162b2 (Pfizer-BioNTech) 疫苗免疫反应较低相关的危险因素.
- 为了将幽默反应 (IgG抗峰值水平) 与临床和人口因素相关联.
- 在这个高风险队列中确定弱疫苗反应的预测因子.
主要方法:
- 在接受BNT-162b2疫苗的血液透析患者中进行了一项观察前性研究.
- 特定的抗尖峰IgG水平以每毫升 (AU/mL) 的任意单位测量.
- 将IgG水平与各种风险因素进行比较,包括并发症指数,完整的副激素 (iPTH),白蛋白,年龄,性别和血管接入类型.
主要成果:
- 幽默反应与两个疫苗剂量后的查尔森并发症指数 (CCI) 和iPTH水平有很强的相关性.
- 没有反应 (NR) 与女性性别,较低的白蛋白和较低的IPTH相关.
- 弱反应 (WR) 与较高的CCI,年龄较大,较低的IPTH和较低的白蛋白有关. 一个回归模型使用CCI,男性性别和中央静脉导管 (CVC) 预测了WR.
结论:
- 高龄,较高的CCI,较低的IPTH和白蛋白,以及CVC使用与HD患者的疫苗反应减少有关.
- 伴随性疾病负担似乎比单独的年龄更有效地预测疫苗反应不佳的间接预测因素.
- 这些发现凸显了针对血液透析患者群体量身定制的疫苗接种策略和监测的需要.
相关概念视频
01:24Hemodialysis II: Procedure and Complications
27
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
27
01:25Hemodialysis III: Nursing Management
31
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
31
01:25Hemodialysis I: Introduction
39
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
39
01:24Chronic Kidney Disease II: Clinical Manifestations
16
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
16
01:27Dialysis
346
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
346
01:11Renal Failure: Dose Adjustments
109
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
109